Goldberg Andrew D.
Reporting Owner SEC Filing List

CIK: 0001827722
Form Filer Subject Company Filing Agent Date Actions
4Statement of changes in beneficial owner...Goldberg Andrew D. 06/29/2026
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc. 06/29/2026
4Statement of changes in beneficial owner...Goldberg Andrew D. 06/16/2026
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc. 06/16/2026
3Initial statement of beneficial ownershi...Goldberg Andrew D. Donnelley Financial Solutions /fa/ 04/21/2026
3Initial statement of beneficial ownershi...Achieve Life Sciences, Inc. Donnelley Financial Solutions /fa/ 04/21/2026
4Statement of changes in beneficial owner...Goldberg Andrew D. Donnelley Financial Solutions /fa/ 04/21/2026
4Statement of changes in beneficial owner...Achieve Life Sciences, Inc. Donnelley Financial Solutions /fa/ 04/21/2026
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. /fa 06/16/2025
4Statement of changes in beneficial owner...Goldberg Andrew D. Tarsus Pharmaceuticals, Inc. /fa 06/16/2025
Load More

Goldberg Andrew D. 's Ownership Transactions

Issuer Filing
Date
Transaction
Date
Transaction
Type
Shares Price Total Amt Shares Owned